These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 8984259)

  • 1. [IBM, money, calcium antagonists and bias].
    Hernborg A
    Lakartidningen; 1996 Nov; 93(46):4136. PubMed ID: 8984259
    [No Abstract]   [Full Text] [Related]  

  • 2. [ACCOMPLISH and the risks with company sponsored clinical trials].
    Furberg C
    Lakartidningen; 2009 Feb 11-17; 106(7):450. PubMed ID: 19350775
    [No Abstract]   [Full Text] [Related]  

  • 3. Conflict of interest in the debate over calcium-channel antagonists.
    Strandgaard S
    N Engl J Med; 1998 Jun; 338(23):1697-8. PubMed ID: 9616065
    [No Abstract]   [Full Text] [Related]  

  • 4. Influencing prescribing patterns.
    Huston P; Campbell NR
    Can Fam Physician; 1998 Feb; 44():221-3, 228-30. PubMed ID: 9512821
    [No Abstract]   [Full Text] [Related]  

  • 5. Dear doctor ... regarding calcium channel blockers.
    Stryer DB; Lurie P; Bero LA
    JAMA; 1996 Feb; 275(7):517-9. PubMed ID: 8606469
    [No Abstract]   [Full Text] [Related]  

  • 6. Bias in case-control studies of calcium antagonists.
    Walker AM; Johnson ES
    Am J Cardiol; 1996 Aug; 78(3):380. PubMed ID: 8759830
    [No Abstract]   [Full Text] [Related]  

  • 7. Industry money skews drug overviews.
    Giles J
    Nature; 2005 Sep; 437(7058):458-9. PubMed ID: 16177748
    [No Abstract]   [Full Text] [Related]  

  • 8. [Conflict of interest].
    Heinzl S
    Med Monatsschr Pharm; 1998 Feb; 21(2):29. PubMed ID: 9531788
    [No Abstract]   [Full Text] [Related]  

  • 9. [More stringent requirements in connection with the choice of drugs. Members of the drug committees in Stockholm deliver an annual declaration of challengeability].
    Sjöqvist F
    Lakartidningen; 2001 Feb; 98(6):541-3. PubMed ID: 11475240
    [No Abstract]   [Full Text] [Related]  

  • 10. PHARMAC responds to Stewart Mann on dihydropyridine calcium channel antagonists.
    Davies A; Metcalfe S; Moodie P; McNee W
    N Z Med J; 2005 Aug; 118(1220):U1621. PubMed ID: 16132079
    [No Abstract]   [Full Text] [Related]  

  • 11. [Drug information: a company convicted for advertising without permission from the Medical Products Agency].
    Lakartidningen; 1997 Feb; 94(6):449. PubMed ID: 9053698
    [No Abstract]   [Full Text] [Related]  

  • 12. Conflict of interest in the debate over calcium-channel antagonists.
    Opie L
    N Engl J Med; 1998 Jun; 338(23):1696-7; author reply 1697-8. PubMed ID: 9616064
    [No Abstract]   [Full Text] [Related]  

  • 13. [A clear winner and two losers].
    Furberg C
    Lakartidningen; 2009 Mar 25-31; 106(13):953. PubMed ID: 19441201
    [No Abstract]   [Full Text] [Related]  

  • 14. Calcium-channel antagonists in cardiovascular disease.
    Holdright DR
    Br J Hosp Med; 1997 Jun 4-17; 57(11):552-6. PubMed ID: 9307671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker.
    Kuti EL; Baker WL; White CM
    Curr Med Res Opin; 2007 Jun; 23(6):1239-44. PubMed ID: 17559720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive drug treatment in a Swedish community: Skaraborg Hypertension and Diabetes Project.
    Bøg-Hansen E; Lindblad U; Ranstam J; Melander A; Råstam L
    Pharmacoepidemiol Drug Saf; 2002; 11(1):45-54. PubMed ID: 11998551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive persistence and drug class.
    Marentette MA; Gerth WC; Billings DK; Zarnke KB
    Can J Cardiol; 2002 Jun; 18(6):649-56. PubMed ID: 12107422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of calcium antagonists on coronary artery spasm and prevention of restenosis after angioplasty].
    Kocurek A; Piwowarska W
    Przegl Lek; 1997; 54(1):37-42. PubMed ID: 9190633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium-channel blockers for Raynaud's phenomenon in systemic sclerosis.
    Thompson AE; Shea B; Welch V; Fenlon D; Pope JE
    Arthritis Rheum; 2001 Aug; 44(8):1841-7. PubMed ID: 11508437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re: Prospective reinfaction outcomes in the Thrombolytic Era Cardizem CD Trial (PROTECT).
    Goodman S; Langer A
    Can J Cardiol; 1997 Jul; 13(7):693, 696. PubMed ID: 9251584
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.